Literature DB >> 20609610

Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.

Tassadit Aït-Abdesselam, Thierry Lequerré, Bruno Legallicier, Arnaud François, Xavier Le Loët, Olivier Vittecoq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20609610     DOI： 10.1016/j.jbspin.2010.04.018

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  A case of cryopyrin-associated periodic syndrome with kidney transplant failure.

Authors:  Rie Imaizumi; Yasuo Ishii; Katsuyuki Miki; Shinji Kudo; Toru Murakami; Ichiro Koyama; Ichiro Nakajima; Shohei Fuchinoue; Yasushi Kawaguchi; Atsuo Taniguchi; Satoshi Teraoka
Journal:  CEN Case Rep       Date:  2014-06-14

Review 2.  Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.

Authors:  Stefano Gentileschi; Donato Rigante; Antonio Vitale; Jurgen Sota; Bruno Frediani; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-23       Impact factor: 2.980

Review 3.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 4.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2015-07-23       Impact factor: 7.580

Review 5.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 6.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Authors:  Charles A Dinarello; Anna Simon; Jos W M van der Meer
Journal:  Nat Rev Drug Discov       Date:  2012-08       Impact factor: 84.694

Review 7.  Anakinra Therapy for Non-cancer Inflammatory Diseases.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.